Literature DB >> 22388793

Muscle weakness, health status and frequency of exacerbations in chronic obstructive pulmonary disease.

Khalid Ansari1, Niall Keaney, Ian Taylor, Graham Burns, Malcolm Farrow.   

Abstract

BACKGROUND: Multiple factors contribute to muscle weakness and reduced muscle mass in chronic obstructive pulmonary disease (COPD) and this impacts patients' quality of life. One factor implicated in this process is systemic inflammation, an accompaniment of acute exacerbations. Recurrent exacerbations are associated with lower health status. This study examines the relationship between muscle weaknesses, health status and exacerbation frequency in a cohort of patients with COPD.
METHODS: This is an observational study of 188 (95 female) patients with COPD attending two hospital clinics in the northeast of England between 2004 and 2007. We measured spirometry, body mass index, health status (St George's Respiratory Questionnaire) and grip strength and recorded Medical Research Council dyspnoea scores and the frequency of exacerbations in the previous year.
RESULTS: Patients were aged 72.5±8.3 years (data expressed as mean±SD) with Medical Research Council score of 3.6±0.8, forced expiratory volume in one second (FEV(1)) of 49.2±21.5 per cent predicted and a total St George's Respiratory Questionnaire score of 72.2±15.5. Grip strength, expressed as per cent predicted, was 72.0±21.8 in men and 81.0±18.2 in women. Exacerbations ranged from zero to five in the previous year and there were associations of reduced grip strength with exacerbation frequency (χ(2)=9.634; p=0.0019) and lower health status (χ(2)=34.00; p<0.001).
CONCLUSION: Our data clearly demonstrate that reduction in grip strength occurs more frequently and to a greater extent in patients with a history of frequent exacerbations and is associated with reduced health status.

Entities:  

Mesh:

Year:  2012        PMID: 22388793     DOI: 10.1136/postgradmedj-2011-130293

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  9 in total

Review 1.  Nutritional status and muscle dysfunction in chronic respiratory diseases: stable phase versus acute exacerbations.

Authors:  Joaquim Gea; Antoni Sancho-Muñoz; Roberto Chalela
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

Review 2.  Muscle dysfunction in chronic obstructive pulmonary disease: update on causes and biological findings.

Authors:  Joaquim Gea; Sergi Pascual; Carme Casadevall; Mauricio Orozco-Levi; Esther Barreiro
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

3.  Bufei Jianpi granules improve skeletal muscle and mitochondrial dysfunction in rats with chronic obstructive pulmonary disease.

Authors:  Yuqiong Dong; Ya Li; Yafei Sun; Jing Mao; Fengjia Yao; Yange Tian; Lili Wang; Linlin Li; Suyun Li; Jiansheng Li
Journal:  BMC Complement Altern Med       Date:  2015-03-10       Impact factor: 3.659

4.  Serum Amyloid A Induces Toll-Like Receptor 2-Dependent Inflammatory Cytokine Expression and Atrophy in C2C12 Skeletal Muscle Myotubes.

Authors:  Samantha L Passey; Steven Bozinovski; Ross Vlahos; Gary P Anderson; Michelle J Hansen
Journal:  PLoS One       Date:  2016-01-19       Impact factor: 3.240

5.  A simple and rapid test of physical performance inchronic obstructive pulmonary disease.

Authors:  Ali Mufraih Albarrati; Nichola S Gale; Stephanie Enright; Margaret M Munnery; John R Cockcroft; Dennis J Shale
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-08-02

6.  Daily physical activity and related risk factors in COPD.

Authors:  Ali M Albarrati; Nichola S Gale; Maggie M Munnery; John R Cockcroft; Dennis J Shale
Journal:  BMC Pulm Med       Date:  2020-03-05       Impact factor: 3.317

7.  Does hand grip strength decrease in chronic obstructive pulmonary disease exacerbation? A cross-sectional study

Authors:  Zeynep Turan; Özlem Özyemişçi Taşkıran; Zeynep Erden; Nurdan Köktürk; Gülçin Kaymak Karataş
Journal:  Turk J Med Sci       Date:  2019-06-18       Impact factor: 0.973

8.  Frailty in Chronic Obstructive Pulmonary Disease and Risk of Exacerbations and Hospitalizations.

Authors:  Nathan Yee; Emily R Locke; Kenneth C Pike; Zijing Chen; Jungeun Lee; Joe C Huang; Huong Q Nguyen; Vincent S Fan
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-08-11

9.  Rationale and design of REGULATE: an observational study protocol for relationship between plasma metabolome and the efficacy of systemic glucocorticoid in acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Qiu-Yu Li; Zhuo-Yu An; Zi-Han Pan; Rui-Ying Qi
Journal:  BMC Pulm Med       Date:  2021-07-28       Impact factor: 3.317

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.